Hester Biosciences Ltd Annually Results

Gross Sales

311.1

304.55

266.09

235.01

214.33

Excise Duty

0

0

0

0

0

Net Sales

311.1

304.55

266.09

235.01

214.33

Other Operating Income

0

0

0

0

0

Other Income

8.02

15.25

19.56

14.16

4.68

Total Income

319.13

319.79

285.65

249.17

219.02

Total Expenditure

250.05

250.89

215.48

175.02

149

PBIDT

69.08

68.9

70.17

74.15

70.02

Interest

12.7

19.78

9.32

4.06

6.6

PBDT

56.37

49.13

60.85

70.08

63.42

Depreciation

16.8

17.17

20.7

16.58

13.31

Minority Interest Before NP

0

0

0

0

0

Tax

12.22

10.73

11.28

14.78

16.95

Deferred Tax

-1.48

0.06

0.84

-0.77

-1.54

Reported Profit After Tax

28.83

21.17

28.04

39.48

34.7

Minority Interest After NP

1.34

2.28

1.41

0.16

0.27

Net Profit after Minority Interest

27.49

18.89

26.63

39.32

34.43

Extra-ordinary Items

0

0

0

0

-2.2

Adjusted Profit After Extra-ordinary item

27.49

18.89

26.63

39.32

36.63

EPS (Unit Curr.)

33.89

24.88

32.96

46.41

40.79

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

70

60

80

100

100

Equity

8.51

8.51

8.51

8.51

8.51

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.2

22.62

26.37

31.55

32.66

PBDTM(%)

18.11

16.13

22.86

29.82

29.58

PATM(%)

9.26

6.95

10.53

16.79

16.18